Category
Bortezomib
CAS Number
NA
Molecular Formula
C28H34BN5O5
Molecular Weight
531.4 g/mol
Synonym

[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-[[(2R)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]propanoyl]amino]butyl]boronic acid; ((R)-3-Methyl-1-((S)-3-phenyl-2-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)propanamido)butyl)boronic Acid; Boronic Acid, ((R)-3-methyl-1-((S)-3-phenyl-2-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)propanamido)butyl); Bortezomib D-phenylalanyl analog;Bortezomib D-Phenylalanyl Analog (USP)

Keywords
Intermediates
Chiral standards
boron derivatives
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Bortezomib Related Compound P is a chemical species structurally related to Bortezomib. It may arise as a synthetic intermediate, degradation product, or minor by-product during manufacturing. While it is not the active drug, its presence is monitored and controlled in pharmaceutical formulations to ensure safety, stability, and consistent therapeutic efficacy of bortezomib.